Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Nele Vandenbussche

Awards & Distinctions

5 Results

2025

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Nele VandenbusscheRenske ImschootBéatrice LintermansLode DenolfJoachim TaminauCharlotte FieuwsGeert BerxKris GevaertKathleen Claes

U Journal Article in Molecular Oncology

Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancreatic cancer (PeRFormanCe) : a multicenter prospective trial-trial protocol

Luis Filipe Abreu de CarvalhoFilip GryspeerdtWim CeelenKaren GeboesSuzane Moura RibeiroAnne HoorensNele VandenbusscheKathleen ClaesClarisse LecluyseAliaksandr Anisau et al.

A1 Journal Article in BMC SURGERY

2024

Towards improved Parsortix® efficiency for circulating tumor cell enrichment in pancreatic cancer

Nele VandenbusscheBéatrice LintermansTijs MerckaertCharlotte FieuwsKris GevaertKathleen Claes

2023

Assessing recovery rates of mesenchymal and epithelial pancreatic tumor cells using the Parsortix system

Nele VandenbusscheBram PartonTijs MerckaertCharlotte FieuwsKris GevaertKathleen Claes

2022

Liquid biopsies to predict surgical resectability after FOLFIRINOX chemotherapy in patients with locally advanced and borderline resectable pancreatic ductal adenocarcinoma

Nele VandenbusscheLuis Abreu De CarvalhoKris GevaertFrederik BerrevoetKathleen Claes